These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 4605187

  • 1. Suppression of uterine activity and abortion by inhibition of prostaglandin synthesis.
    Csapo AI, Henzl MR, Kaihola HL, Kivikoski A, Pulkkinen MO.
    Prostaglandins; 1974 Jul 10; 7(1):39-47. PubMed ID: 4605187
    [Abstract] [Full Text] [Related]

  • 2. The effect of luteectomy-induced progesterone-withdrawal on the oxytocin and prostaglandin response of the first trimester pregnant human uterus.
    Csapo AI, Pulkkinen MO, Kaihola HL.
    Prostaglandins; 1973 Sep 10; 4(3):421-9. PubMed ID: 4783575
    [Abstract] [Full Text] [Related]

  • 3. Midtrimester pregnancy interruption and the placental progesterone levels.
    Aleem FA, Schulman H.
    Prostaglandins; 1975 Mar 10; 9(3):495-500. PubMed ID: 1138306
    [Abstract] [Full Text] [Related]

  • 4. Prostaglandin F2 alpha, oxytocin, and uterine activation in hypertonic saline-induced abortions.
    Fuchs AR, Rasmussen AB, Rehnström J, Toth M.
    Am J Obstet Gynecol; 1984 Sep 01; 150(1):27-32. PubMed ID: 6476024
    [Abstract] [Full Text] [Related]

  • 5. Comparison of prostaglandin F2alpha and hypertonic saline for induction of midtrimester abortion.
    Lauersen NH, Wilson KH, Beling CG, Fuchs F.
    Am J Obstet Gynecol; 1974 Dec 01; 120(7):875-9. PubMed ID: 4429105
    [Abstract] [Full Text] [Related]

  • 6. Induction of therapeutic abortion using either extra-amniotic prostaglandin F-2-alpha or hypertonic saline followed by oxytocin.
    Lange AP, Secher NJ, Pedersen GT.
    Prostaglandins; 1974 Apr 25; 6(2):149-57. PubMed ID: 4847514
    [Abstract] [Full Text] [Related]

  • 7. Progesterone inhibition in mid-trimester termination of pregnancy: physiological and clinical effects.
    Selinger M, Mackenzie IZ, Gillmer MD, Phipps SL, Ferguson J.
    Br J Obstet Gynaecol; 1987 Dec 25; 94(12):1218-22. PubMed ID: 3322376
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Uterine contractility during pregnancy and the effect of abortifacient drugs.
    Bygdeman M, Swahn ML.
    Baillieres Clin Obstet Gynaecol; 1990 Jun 25; 4(2):249-61. PubMed ID: 2225598
    [Abstract] [Full Text] [Related]

  • 10. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S, Zador G, Nygren KG, Wide L.
    Gynecol Obstet Invest; 1981 Jun 25; 12(4):203-10. PubMed ID: 7250783
    [Abstract] [Full Text] [Related]

  • 11. Midtrimester intra-aminotic administration of prostaglandin F2alpha in combination with an hyperosmolar urea solution: effect upon plasma levels of estradiol, progesterone, and human placental lactogen (HPL).
    Sher G, Katz M.
    Acta Obstet Gynecol Scand; 1978 Jun 25; 57(3):223-5. PubMed ID: 665164
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Massive initial prostaglandin impact in postconceptional therapy.
    Csapo AI, Kivikoski A, Wiest WG.
    Prostaglandins; 1972 Aug 25; 2(2):125-34. PubMed ID: 4653230
    [Abstract] [Full Text] [Related]

  • 14. On the mechanism of midtrimester abortions induced by prostaglandin "impact".
    Saldana L, Schulman H, Yang WH.
    Prostaglandins; 1973 Jun 25; 3(6):847-58. PubMed ID: 4729604
    [Abstract] [Full Text] [Related]

  • 15. Plasma progesterone and oestradiol-17beta changes during abortion induced by prostaglandin F2alpha.
    Tyack AJ, Lambadarios C, Parsons RJ, Stewart CR, Cooke ID.
    J Obstet Gynaecol Br Commonw; 1974 Jan 25; 81(1):52-6. PubMed ID: 4818317
    [Abstract] [Full Text] [Related]

  • 16. Cervicovaginal fistula: an apparent increased incidence with prostaglandin F2alpha.
    Lowensohn R, Ballard C.
    Am J Obstet Gynecol; 1974 Aug 15; 119(8):1057-61. PubMed ID: 4847442
    [Abstract] [Full Text] [Related]

  • 17. Continuous extraovular administration of prostaglandin F2alpha for midtrimester abortion.
    Lauersen NH, Wilson KH.
    Am J Obstet Gynecol; 1974 Sep 15; 120(2):273-80. PubMed ID: 4412615
    [Abstract] [Full Text] [Related]

  • 18. Prostaglandin-oxytocin enhancement.
    Seppälä M, Vara P.
    Br Med J; 1972 Mar 18; 1(5802):747. PubMed ID: 5015335
    [Abstract] [Full Text] [Related]

  • 19. Midtrimester abortion induced by single intra-amniotic instillation of two dose schedules of 15(S)-15-methyl-prostaglandin F2alpha.
    Lauersen NH, Wilson KH.
    Prostaglandins; 1975 Apr 18; 9(4):617-25. PubMed ID: 1153812
    [Abstract] [Full Text] [Related]

  • 20. The efficacy and acceptability of the "prostaglandin impact" in inducing complete abortion during the second week after the missed menstrual period.
    Csapo AI, Mocsary P, Nagy T, Kaihola HL.
    Prostaglandins; 1973 Feb 18; 3(2):125-39. PubMed ID: 4729565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.